Cytokines in Thyroid-Associated Ophthalmopathy
Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves’ orbitopathy (GO), is a complex autoimmune condition causing visual impairment, disfigurement, and harm to patients’ physical and mental health. The pathogenesis of TAO has not been fully elucidated, and the m...
Saved in:
Main Authors: | Pengbo Zhang, Huang Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/2528046 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid‐Associated Ophthalmopathy
by: Defu Li, et al.
Published: (2025-01-01) -
Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma
by: Daisuke Murayama, et al.
Published: (2021-01-01) -
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
by: Xin-Yu Zhu, et al.
Published: (2025-01-01) -
Correlation between Peripheral T Cell Subsets and the Activity of Thyroid-Associated Ophthalmopathy
by: Hong Hu, et al.
Published: (2022-01-01) -
Contrast Sensitivity of Thyroid Associated Ophthalmopathy Patients without Obvious Optic Neuropathy
by: Ümit Beden, et al.
Published: (2013-01-01)